Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Charles Edelstein to Enzyme Inhibitors

This is a "connection" page, showing publications Charles Edelstein has written about Enzyme Inhibitors.

 
Connection Strength
 
 
 
0.349
 
  1. Tao Y, Kim J, Faubel S, Wu JC, Falk SA, Schrier RW, Edelstein CL. Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease. Proc Natl Acad Sci U S A. 2005 May 10; 102(19):6954-9.
    View in: PubMed
    Score: 0.173
  2. Chaudhary A, He Z, Atwood DJ, Miyazaki M, Oto OA, Davidoff A, Edelstein CL. Raising serum uric acid with a uricase inhibitor worsens PKD in rat and mouse models. Am J Physiol Renal Physiol. 2024 06 01; 326(6):F1004-F1015.
    View in: PubMed
    Score: 0.161
  3. Lelamali K, Wang W, Gengaro P, Edelstein C, Schrier RW. Effects of nitric oxide and peroxynitrite on endotoxin-induced leukocyte adhesion to endothelium. J Cell Physiol. 2001 Sep; 188(3):337-42.
    View in: PubMed
    Score: 0.008
  4. Ling H, Gengaro PE, Edelstein CL, Martin PY, Wangsiripaisan A, Nemenoff R, Schrier RW. Effect of hypoxia on proximal tubules isolated from nitric oxide synthase knockout mice. Kidney Int. 1998 Jun; 53(6):1642-6.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)